Xenon Pharmaceuticals Inc
XENE · NASDAQ
Xenon is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. The Company is advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy.
Market Data
Price
$60.61
-2.15 (-3.43%)
Market Cap$5.15B
P/E Ratio—
EPS$—
52W High$62.91
52W Low$26.74
Beta0.89
Data from Finnhub · Updated Mar 11, 2026